EC Concludes Exploratory Talks with J&J to Supply 200M Doses of COVID-19 Vaccine

 EC Concludes Exploratory Talks with J&J to Supply 200M Doses of COVID-19 Vaccine

EC Concludes Exploratory Talks with J&J to Supply 200M Doses of COVID-19 Vaccine

Shots:

  • The EC has the contractual framework in place to purchase the initial 200M doses on behalf of all EU Member States once the vaccine has proven safe and effective. The agreement includes an option to purchase up to an additional 200M dose
  • If approved, the EC expects to facilitate a process for the allocation of the vaccine doses among the member states.
  • The exploratory talks concluded today are intended to result in an Advance Purchase Agreement to be financed with the Emergency Support Instrument, which has funds for vaccines with different profiles and produced by different companies

Click here to­ read full press release/ article | Ref: European Commission | Image: USA Today

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post